« Previous
Next »
Neurobiology of Aging
Volume 31, Issue 10
, Pages 1679-1689
, October 2010
Potential amyloid plaque-specific peptides for the diagnosis of Alzheimer's disease
References
- . Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy. Proc. Natl. Acad. Sci. U.S.A. 1999;96(24):14079–14084
- . In vivo measurement of plaque burden in a mouse model of Alzheimer's disease. MRI. 2006;24:1011–1017
- . Magnetic resonance imaging of inflammation with a specific selectin-targeted contrast agent. Magn. Reson. Med. 2005;53(4):800–807
- . Magnetic resonance imaging of iron deposition in neurological disorders. Top. Magn. Reson. Imaging. 2006;17(1):31–40
- . Synthesis and relaxometry of high-generation (G
=
5, 7, 9, and 10) PAMAM dendrimer-DOTA-gadolinium chelates. J. Magn. Reson. Imaging. 1999;9(2):348–352 - . Molecular imaging of αvβ3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA. Cardiovasc. Res. 2008;78(1):148–157
- . Phage Display: Practical Approach. New York: Oxford University Press Inc.; 2004;
- . Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice. Neurobiol. Aging. 2007;
- . Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. Endocr. Rev. 2008;29(3):303–316
- . Distinct sites of intracellular production for Alzheimer's disease A beta 40/42 amyloid peptides. Nat. Med. 1997;3(9):1016–1020
- . F-19 and H-1 MRI detection of amyloid beta plaques in vivo. Nat. Neurosci. 2005;8(4):527–533
- . The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry. 1999;38(24):7609–7616
- . The toxicity in-vitro of beta-amyloid protein. Biochem. J. 1995;311:1–16
- . In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent. Magn. Reson. Med. 2004;52(6):1263–1271
- . What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?. Neurology. 2007;69(9):871–877
- . Identification of peptides that specifically bind A beta(1–40) amyloid in vitro and amyloid plaques in Alzheimer's disease brain using phage display. Neurobiol. Dis. 2003;14(1):146–156
- . Nanoparticulate systems for brain delivery of drugs. Adv. Drug Deliv. Rev. 2001;47(1):65–81
- . Visualization of beta-amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents. Magn. Reson. Med. 2004;52(3):538–544
- . Amyloid plaque imaging in vivo: current achievement and future prospects. Eur. J. Nucl. Med. Mol. Imaging. 2008;35(s1):s46–s50
- . Phage display affords peptides that modulate beta-amyloid aggregation. J. Am. Chem. Soc. 2006;128(36):11882–11889
- . Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood–brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques. Biochemistry. 2004;43(20):6064–6075
- . PD98059 prevents neurite degeneration induced by fibrillary beta-amyloid in mature hippocampal neurons. J. Neurochem. 2000;74(1):125–133
- . Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease. Neurochem. Int. 2001;39(5/6):333–340
- . Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press; 1989;
- . From phage display to magnetophage, a new tool for magnetic resonance molecular imaging. Bioconjug. Chem. 2007;18(4):1251–1258
- . A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice. Neurobiol. Aging. 2007;
- . Amyloid Proteins. The Beta Sheet Conformation and Disease. New York: WILEY-VCH; 2005;
- . Phage display. Chem. Rev. 1997;97(2):391–410
- . Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons. Am. J. Pathol. 2000;157(4):1283–1298
- . Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimer's disease. Magn. Reson. Med. 2005;53(3):607–613
- . Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging. Magn. Reson. Med. 2003;50(2):293–302
- . Molecular imaging. Radiology. 2001;219(2):316–333
- . Selection of d-amino-acid peptides that bind to Alzheimer's disease amyloid peptide A beta(1–42) by mirror image phage display. Chembiochem. 2003;4(8):748–753
- . Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. Bioconjug. Chem. 2002;13(4):840–844
- . Phage-displayed peptide libraries. Curr. Opin. Biotechnol. 1998;9(4):427–436
PII: S0197-4580(08)00356-4
doi: 10.1016/j.neurobiolaging.2008.09.021
© 2008 Elsevier Inc. All rights reserved.
« Previous
Next »
Neurobiology of Aging
Volume 31, Issue 10
, Pages 1679-1689
, October 2010
